VSJ-110 for Dry Eye

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Recruiting

Sponsor: Vanda Pharmaceuticals

Prior Safety Data

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Eligibility Criteria

This trial is for adults over 18 years old with dry eye syndrome who can follow the study's instructions and attend all visits. Participants must consent to the study rules and privacy regulations. Those using certain medications that are not allowed during the trial cannot participate.

Inclusion Criteria

Provide written informed consent and sign the HIPAA form

I am 18 years old or older.

I can follow all study instructions and attend all visits.

Exclusion Criteria

I am not taking any medications that are not allowed in the study.

Treatment Details

Interventions

VSJ-110 (Other)

Trial OverviewThe trial is testing VSJ-110, a potential new treatment for dry eye, against a placebo (a substance with no therapeutic effect). The goal is to see if VSJ-110 is safe and works better than taking nothing at all.

Participant Groups

2Treatment groups

Experimental Treatment

Placebo Group

Group I: VSJ-110 SolutionExperimental Treatment1 Intervention

Group II: Placebo SolutionPlacebo Group1 Intervention